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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYEpigenetic regulation serves as the basis for stem cell differentiation into distinct cell types, but it is unclear how global epigenetic
changes are regulated during this process. Here, we tested the hypothesis that global chromatin organization affects the lineage
potential of stem cells and that manipulation of chromatin dynamics influences stem cell function. Using nuclease sensitivity
assays, we found a progressive decrease in chromatin digestion among pluripotent embryonic stem cells (ESCs), multipotent he-
matopoietic stem cells (HSCs), and mature hematopoietic cells. Quantitative high-resolution microscopy revealed that ESCs
contain significantly more euchromatin than HSCs, with a further reduction in mature cells. Increased cellular maturation also
led to heterochromatin localization to the nuclear periphery. Functionally, prevention of heterochromatin formation by inhibi-
tion of the histone methyltransferase G9A resulted in delayed HSC differentiation. Our results demonstrate global chromatin
rearrangements during stem cell differentiation and that heterochromatin formation by H3K9 methylation regulates HSC differ-
entiation.INTRODUCTION
Epigenetic mechanisms play a major role in maintaining
stem cell identity as well as in regulating stem cell fate
decisions. Intense desire to predict and control cell differ-
entiation and dedifferentiation has rapidly led to deeper
insights into the epigenetic regulation of stem cell func-
tion. Many of these recent insights have been obtained
from embryonic stem cells (ESCs) because the ability to
expand and differentiate these cells ex vivo provides ac-
cess to large numbers of cells at various stages of differen-
tiation. ESCs have been reported to contain a relatively
open chromatin conformation with hyperdynamic bind-
ing of chromatin proteins (Meshorer et al., 2006), accom-
panied by bivalent histone modifications (Azuara et al.,
2006; Bernstein et al., 2006) and transcriptional hyperac-
tivity compared to differentiated cells (Efroni et al., 2008).
Immature cells also harbor a higher proportion of DNaseI
hypersensitive sites, and their loss or relocation upon dif-
ferentiation suggests major remodeling of the epigenetic
landscape (Stergachis et al., 2013). Furthermore, chro-
matin remodeling proteins such as CHD1 and esBAF
appear essential for the open chromatin state in ESCs
and preservation of self-renewal capacity and pluripo-
tency (Gaspar-Maia et al., 2009; Ho et al., 2009). These ob-
servations suggest that chromatin conformation is very728 Stem Cell Reports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 Thedynamic in ESCs, with dramatic changes occurring upon
differentiation.
Progress has also beenmade in mapping the epigenomes
of adult stem cells, including DNA methylation and his-
tone modifications of hematopoietic stem cells (HSCs)
and their progeny. However, while the hierarchy and line-
age potential of hematopoietic cell populations is well
characterized (Boyer et al., 2011, 2012; Forsberg et al.,
2006), much less is known about the epigenetic mecha-
nisms governing hematopoietic fate decisions. There are
huge gaps in our understanding of the characteristics of
chromatin structure in HSCs, how it compares to ESCs,
and how it is remodeled upon differentiation. We also
don’t understand the functional consequences of large-
scale chromatin remodeling, which are the master regula-
tors of chromatin architecture, or how these regulators
control lineage potential.
Here, we tested the hypothesis that stem cells undergo
significant changes in global chromatin conformation
upon differentiation and that lineage potential is a direct
consequence of the global chromatin composition and dis-
tribution. Our study demonstrates that global chromatin
architecture is distinctly different among cells of diverse
lineage potential and that proper transition from euchro-
matin to heterochromatin is required for efficient stem
cell differentiation.Authors
RESULTS
Nuclease Sensitivity Progressively Decreases upon
Stem Cell Differentiation
To test whether there are substantial differences in chro-
matin condensation in cells with different lineage poten-
tial, we measured the relative DNaseI sensitivity of mouse
ESCs and of primary hematopoietic stem and progenitor
cells (HSPCs; defined as c-kit+LinSca1+ [KLS] bonemarrow
[BM] cells) andmature hematopoietic cells isolated by fluo-
rescence-activated cell sorting (FACS) frommouse BM. Cell
populations were subjected to DNaseI digestion, and the
size of the fragmentedDNAwas analyzed by gel electropho-
resis to assess the relativedegreeof chromatin condensation
(Sabo et al., 2006). Strikingly, we found that ESCs displayed
thehighestdegreeofDNaseI sensitivity, followedbyHSPCs,
and thenmature cells (Figure 1A). Interestingly, further sep-
aration of BM cells into an HSC-enriched fraction (Flk2
KLS cells) and myeloid progenitors (granulocyte/macro-
phage progenitors [GMPs] andmegakaryocyte/erythrocyte
progenitors [MEPs]) did not result in significantly different
DNaseI digestion, although therewas a trend towardhigher
sensitivity for myeloid progenitors over HSCs (Figure 1A).
HSCs that had been induced to cycle in vivo by injecting
mice with cytoxan/G-CSF prior to HSC isolation (Morrison
et al., 1997; Smith-Berdan et al., 2011) did not display
significantly different DNaseI sensitivity compared to
steady-state quiescent HSCs (Figure S1A). Thus, cell-cycle
status did not directly correlate with the nuclease
sensitivity.
To determine whether the differential nuclease sensi-
tivity is manifested in chromatin linker regions, we per-
formed analogous experiments with micrococcal nuclease
(MNase), an enzyme that induces double-strand breaks spe-
cifically in nucleosome linker regions. We found that ESCs
displayed significantly higher sensitivity to MNase diges-
tion compared to HSPCs (Figure 1B), possibly because of
their differential expression of linker histone variants
(Terme et al., 2011). In contrast, we found no significant
differences in MNase sensitivity between HSPCs and
mature hematopoietic cells (Figure 1B). This suggests that
the higher DNaseI sensitivity of HSPCs relative to mature
cells is manifested in core histone regions, without signifi-
cant differences in linker histone conformation. Overall,
these results show that nuclease sensitivity correlates
with lineage potential and that there is a progressive global
condensation of chromatin among pluripotent ESCs, mul-
tipotent HSPCs, and fully differentiated blood cells.
Global Levels of Epigenetic Modifications Do Not
Change upon Stem Cell Differentiation
We hypothesized that the observed differences in chro-
matin condensation among ESCs, HSPCs, and mature cellsStem Cell Rcould be due to global differences in either DNA methyl-
ation or histone modifications. However, despite recent
demonstrations of the importance of DNA methylation
for HSC function (Bro¨ske et al., 2009; Challen et al.,
2011; Trowbridge et al., 2009), we did not detect significant
differences in DNA digestion between HSPCs and mature
cells using the restriction enzymes MspI and HpaII (Fig-
ure S1B) (Bernardino et al., 1997). Using immunoblotting,
we also foundno significant differences in the overall levels
of any of the histone marks investigated (H3K4me3, H3Ac,
H4K16Ac, H4K20me1, and H3K36me3 that are usually
associated with active transcription, or H3K27me3,
H3K9me2, and H3K9me3 that usually act as repressive
marks) among ESCs, HSPCs, and fully mature cells (Fig-
ure 1C). Further separation of hematopoietic cells into
more distinct populations also failed to reveal significant
differences in the frequency of histone marks (Figure S1C).
To test the sensitivity of the assay, we treated cells with the
histone deacetylase inhibitor trichostatin A (TSA). This led
to a significant increase in the global levels of histone acet-
ylation (Figure S1C), showing that the immunoblotting
assay was capable of detecting differences in histone modi-
fication. To test whether ELISAs would enable greater
sensitivity and detection of differential levels of modifica-
tions, we established a quantitative nucleosome ELISA
(NU-ELISA; Figure S1D) (Dai et al., 2013). Quantification
of histone modifications of acid-extracted nucleosomes
did not reveal statistically significant differences between
ESCs and mature cells (Figure 1D), despite a measurable in-
crease in H3Ac upon TSA treatment (Figure S1E). qRT-PCR
also showed that the overall expression levels of histoneH1
were comparable between ESCs and mature cells, whereas
both themRNA and protein levels of the nucleosome bind-
ing protein HMGN1 were significantly lower in mature
cells (Figures S1F and S1G). Taken together, these results
suggest that the globally more open chromatin conforma-
tion in ESCs andHSPCs is not due to substantial differences
in overall levels of DNA methylation or individual histone
modifications. Our data are consistent with recent studies
showing that HSC differentiation is accompanied by
changes in DNA methylation at specific genomic loci
without significant changes in overall levels (Ji et al.,
2010) and by quantitative mass spectrometry detecting
only moderate global differences in the levels of histone
modifications betweenmature cells (MEFs) and pluripotent
stem cells (Sridharan et al., 2013).
The Chromatin Architecture of Stem Cells Is Modified
upon Differentiation
Previous studies have shown that ESC differentiation or
perturbation of chromatin remodeling proteins can lead
to significant changes in heterochromatin abundance
and distribution in ESCs (Gaspar-Maia et al., 2009;eports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 The Authors 729
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Figure 1. Progressive Decrease in Nuclease Sensitivity upon Stem Cell Differentiation
(A) Multipotent HSPCs display greater sensitivity to DNaseI digestion than mature hematopoietic cells but lower sensitivity compared to
pluripotent ESCs. Each cell population was incubated with increasing concentrations of DNaseI, followed by DNA separation by gel
electrophoresis (left panels). No significant differences were detected between HSCs and GMPs/MEPs. DNaseI sensitivity was quantified
(middle and right panels) as the amount of digested DNA at equal concentrations of DNaseI (yellow rectangles in left panel). n = 6 in-
dependent experiments. Statistics by one-way ANOVA.
(B) MNase sensitivity assays revealed higher ESC sensitivity to MNase digestion, but no differences between HSPCs and mature he-
matopoietic cells, indicating that nucleosome linker regions are differentially organized in ESCs compared to multipotent and mature
hematopoietic cells. n = 3 independent experiments. Statistics by one-way ANOVA.
(C and D) The global abundance of histone modifications does not change significantly among ESCs, HSPCs, and mature cells. Each
modification was measured using semiquantitative immunoblot analysis (C) or nucleosome ELISA (D). n = 8 and statistics by two-way
ANOVA (C), and n = 3–4 and statistics by t test (D).
Data are means ± SEM; *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not significant; N.D., not determined. See also Figure S1.
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Figure 2. Alterations in Nuclear Architecture and Chromatin Conformation upon Stem Cell Differentiation
(A) High-resolution imaging of ESCs, HSCs, MPPs, GMPs, B cells, and GM cells by electron microscopy (left column) and soft X-ray to-
mography (middle and right columns) displays the organization of hetero- (dark or blue nuclear regions) and euchromatin (light or green
nuclear regions) in a single plane (left and middle) as well as in a 3D reconstruction (right).
(legend continued on next page)
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Meshorer et al., 2006). To test whether differences also exist
between unmanipulated ESCs and freshly isolated HSCs
and their progeny, we analyzed their chromatin conforma-
tion using high-resolution electron microscopy (EM) and
soft X-ray tomography (SXT) (Parkinson et al., 2013). Strik-
ingly, EM revealed a very high content of euchromatin in
ESCs (79% of nuclear area; Figure 2A, images in left col-
umn, and Figure 2B, top). A significant decrease in the
amount of euchromatin was observed in HSCs, multipo-
tent progenitors (MPPs), and GMPs (55%, 53%, and 57%,
respectively) (Figure 2B, middle panel). Mature myeloid
cells and B cells displayed a further significant reduction
in euchromatin area (34% and 37%, respectively).
Next, imaging by SXTand 3D reconstruction of complete
cells allowed us to analyze the entire chromatin content of
cells, quantifying the total volumes of hetero- versus
euchromatin and their spatial distribution throughout
the cell nuclei (McDermott et al., 2009; Parkinson et al.,
2013). Notably, SXT imaging is performed on the entire
cell in its natural hydrated conformation, therefore avoid-
ing potential artifacts in chromatin conformation induced
by cell fixation and single-plane analysis. Strikingly similar
to the EM results, SXT images as single orthoslices revealed
a reduction in the amount of euchromatin among pluripo-
tent ESCs, multipotent stem and progenitor cells, and line-
age-restricted mature cells (Figure 2A, images in middle
column). Quantification of the volumes of each type of
chromatin as a fraction of the nuclear volume demon-
strated the highest percentage of euchromatin in ESCs
(72.6%), followed by MPPs (52.8%), GMPs (53.7%), HSCs
(40.9%), B cells (37.2%), and granulocyte/monocyte
(GM) cells (29.4%) (Figure 2A, images in right column; Fig-
ure 2B, bottom panel; Movies S1, S2, and S3). Surprisingly,
we found that the heterochromatin amount remained un-
altered among the different cell types when measured as
either total absolute area by EM or as volume by SXT (Fig-
ure S1A). Instead, the euchromatin content significantly
decreased upon differentiation, condensing into highly
packed heterochromatin. Independent analyses by both(B) Quantification of the ratios of heterochromatin and euchromatin a
proportion of euchromatin upon stem cell differentiation. The top imag
heterochromatin, illustrating the stark differences between heterochr
8 cells; per cell type in three or more experiments.)
(C) Positive correlation of the amount of euchromatin and nuclear siz
8 cells; per cell type in three or more experiments.)
(D) Theoretical model of a cell nucleus as a perfect sphere and the in
(E) Quantification of the total area of the euchromatin/heterochrom
significantly larger euchromatin/heterochromatin interaction areas t
retical interphase of a perfect disk, designated as 1. (EM, n = 30 cell
(F) ESCs and mature GM cells have the highest degree of nuclear foldin
closest to a theoretical perfect sphere (= 1). (EM, n = 30 cells; SXT, n
Data are means ± SEM; *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not
for EM images in (A); all other scale bars are 2 uM. See also Figure S2
732 Stem Cell Reports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 TheEM and SXT images demonstrated a positive correlation
between nuclear size and the amount of euchromatin, sug-
gesting that nuclear size may be determined predomi-
nantly by the prevalence of euchromatin rather than
heterochromatin content (Figure 2C). Overall, our results
demonstrate that chromatin composition changes with re-
striction of lineage potential from a highly open and eu-
chromatinized state to an increasingly condensed and
silenced heterochromatin conformation.
Wenext analyzed the spatial distribution of chromatin in
cell types of varying lineage potential. To measure the total
surface area of hetero- and euchromatin and the extent of
hetero- or euchromatin interface, we constructed a 3D hy-
pothetical model where: (1) cell nuclei are perfect spheres,
(2) the nuclei are divided in two equal parts of hetero- and
euchromatin, and (3) the interface between them is a regu-
lar disk (Figure 2D). Using the SXT images, we found that
the interface between the two chromatin fractions was
significantly different from that expected for a circular
disk (value = 1) for all cell types. The observed interface
for ESCs, HSCs, MPPs, and GMPs was approximately 10-
fold higher than the model and significantly higher than
for mature GM and B cells (Figure 2E). We also found that
the nuclear shape of HSCs, MPPs, GMPs, and B cells devi-
ated only slightly from a perfect sphere, whereas ESCs
displayed a high degree of nuclear folding (Figure 2F).
Extensive nuclear folding was also evident in GM cells, in
agreementwith their characteristicmorphology (Figure 2A,
bottom images). The high nuclear folding of ESCs and
extensive chromatin interface in stem and progenitor cells
compared tomature cells may reflect amore dynamic chro-
matin structure indicative of greater lineage potential.
Heterochromatin Is Redistributed to the Nuclear
Periphery upon Stem Cell Differentiation
We next tested whether the subcellular distribution
of H3K9me3, a heterochromatin-associated mark, is differ-
entially distributed in the nucleus of cells with different
lineage potential. ESCs or purified hematopoieticrea by EM and volume by SXT revealed significant reductions in the
e depicts examples of EM-based quantification of densely appearing
omatin staining between ESCs and B cells. (EM, n = 30 cells; SXT, n =
e by EM (top) and SXT (bottom) analyses. (EM, n = 30 cells; SXT, n =
terphase between hetero- and euchromatin as a perfect disk.
atin interface by SXT revealed that stem and progenitor cells have
han lineage-committed cells. All cell types deviate from the theo-
s; SXT, n = 8 cells; per cell type in three or more experiments.)
g, quantified as nuclear sphericity, while HSPCs and B cells are the
= 8 cells; per cell type in three or more experiments.)
significant. Statistics by one-way ANOVA. Scale bars represent 4 uM
and Movies S1, S2, and S3.
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subpopulations were incubated with DAPI to label nuclei,
anti-lamin antibodies to label the nuclear envelope, and
anti-H3K9me3 antibodies to label heterochromatin and
then analyzed by confocal microscopy. H3K9me3 accumu-
lated in well-defined foci scattered throughout the nucleus
of ESCs, consistent with previous studies (Gaspar-Maia
et al., 2009). In HSCs and MPPs, H3K9me3 was preferen-
tially localized at the nuclear periphery, overlapping with
the nuclear envelope mark LaminB, with much fewer foci
in the center of the nuclei (Figure 3A). Three-dimensional
analysis of confocal images revealed large numbers of foci
of various sizes located near the nuclear envelope, demon-
strating that heterochromatin foci are present but periph-
erally distributed in HSPCs (Movie S2). Mature cells
demonstrated an even more distinct pericentric distribu-
tion of H3K9me3. Interestingly, GMPs had relatively
dispersed H3K9me3 foci throughout the nucleus, similar
to ESCs (Figure 3A). These visual observations were sub-
stantiated by radial distribution analysis (Figure 3B), with
quantification demonstrating that H3K9me3 in HSCs,
MPPs, GM, B cells, and Tcells wasmainly contained within
the 20% of the nuclear area closest to the nuclear envelope,
whereas a significantly smaller fraction of the total
H3K9me3 in ESCs andGMPswas localized to the periphery
(Figure 3C). To assess heterochromatin localization by an
independent method, we also quantified the distribution
of heterochromatin relative to the nuclear envelope using
SXT. As in the immunohistochemistry (IHC) analyses of
H3K9me3-marked heterochromatin, SXT revealed that
ESCs had the lowest amount of heterochromatin located
near (within 0.5 mm) the nuclear envelope, followed by
GMPs, then HSCs and MPPs, and finally by mature cells
(Figure 3D). Overall, these results show that despite having
similar global levels of H3K9me3 (Figures 1C and 1D), the
spatial distribution of this mark differs significantly among
different cell types. The progressive localization of
H3K9me3 to the nuclear periphery upon cell differentia-
tion generally followed the patterns observed by nuclease
sensitivity (Figure 1) and euchromatin content (Figure 2),
except that GMPs deviate from the ‘‘expected’’ distribution
of pericentric heterochromatin.
H3K9 Methylation by G9A Is Essential for Efficient
HSC Differentiation
To search formolecular regulatorsmediating the condensa-
tion of euchromatin during lineage commitment, we
tested whether inhibitors of chromatin-modifying en-
zymes affected HSC differentiation in vitro. Purified HSCs
were grown in liquid culture with and without inhibitors.
By dose titration for cell viability and analysis of HSC differ-
entiation in response to several different inhibitors, we
found that inhibition of the histone methyltransferase
G9A (EHMT2), an enzyme mediating mono- and di-Stem Cell Rmethylation of H3K9 in euchromatin domains and pro-
moting heterochromatin formation (Barski et al., 2007;
Shinkai and Tachibana, 2011), using the small-molecule in-
hibitor UNC0638 (Vedadi et al., 2011) led to significant
accumulation of HSPCs (Figures 4 and 5A). Accumulation
of HSPCs upon G9A inhibition occurred in both liquid cul-
ture and co-culture of HSCs with AFT024 stromal cells
(Moore et al., 1997) (Figures 4 and 5A and data not shown).
Dose titration showed that total cell numbers started to
decline beyond UNC0638 concentrations of 1 uM. Inter-
estingly, total HSPC numbers, not only their frequency,
increased throughout this concentration range (Figure 4).
This suggested that G9A inhibition may increase self-re-
newing divisions of HSPCs in culture. Indeed, ethynyl de-
oxyuridine (EdU) incorporation experiments revealed
that a significantly higher percentage of HSPCs were in S
phase upon UNC0638 treatment compared to the DMSO
control (56% and 44%, respectively), and fewer cells were
in theG0/G1 phase (38% and 50%) (Figure 5B). In contrast,
the myeloid progenitor population displayed no signifi-
cant shift in cell-cycle status upon UNC0638 treatment
(Figure 5B). These data suggest that UNC0638 promotes
proliferation of HSPCs and that they accumulate due to
lack of differentiation.
Next, to test the functionality of these expanded HSPCs,
we transplanted them into lethally irradiated recipients.
Despite the significant increase inKLS cells, transplantation
of cells from wells seeded with HSCs and grown in liquid
cultured for 24 hr in the presence of UNC0638 resulted in
only aminor increase in reconstitutioncompared to control
cells (Figure 5C). Additional experiments that varied the
length of UNC0638 exposure, the number of transplanted
cells, the conditioning of the recipient mice, and whether
cells were grown in liquid culture or on AFT024 cells, while
leading to significant increases in KLS cells, also failed to
significantly increase the reconstitution levels of transplant
recipients (Figures 5C, S4A, and S4B and data not shown).
Growth in liquid culture for 24 hr or on AFT024 cells for
up to 5 days resulted in long-term engraftment (Figure 5C),
whereas liquid culturing for longer time periods led to only
short-term hematopoietic reconstitution (Figure S4B). The
loss of engraftment potential over time in culture equally
affected untreated and UNC0638-treated cells, indicating
that G9A inhibition was not sufficient to maintain engraft-
able HSCs for prolonged periods in culture. All conditions
led to multilineage readout, with production of red blood
cells, platelets, and nucleated myeloid, B cells, and T cells
at similar ratios between control and UNC0638-treated
cells. Thus, G9A inhibition maintained KLS cells without
affecting lineage output but was insufficient to expand
HSCs with strong long-term engraftment capability.
To test the molecular mechanisms behind UNC0638-
mediated accumulation of HSPCs, we compared the globaleports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 The Authors 733
B 
C 
A DAPI LaminB H3K9me3 
ESC 
HSC 
MPP 
GMP 
T 
B 
GM 
D 
0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.25
0.50
0.75
1.00
Distance (µM)
Vo
lu
m
e 
fra
ct
io
n 
(h
et
er
oc
hr
om
at
in
)
SXT - Distance of 
heterochromatin from nuclear envelope
ESC
HSC
MPP
GMP
GM
B
100% Heterochromatin
Nuclear 
EnvelopeH
SCMP
P
GM
P B T
ES
C
HS
C
MP
P
GM
P B T
0.0
0.2
0.4
0.6
0.8
1.0
%
 o
f n
uc
le
ar
 a
re
a
H3K9me3 Radial distribution
Periphery
Center
****** ***
***
*
****** ***
***
*
0 20 40 60 80 100 120
0
20
40
60
80
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 ESC
H3K9me3
DAPI
0 20 40 60 80 100 120
0
50
100
150
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 HSC
H3K9me3
DAPI
0 20 40 60 80 100 120
0
20
40
60
80
100
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 MPP
H3K9me3
DAPI
0 20 40 60 80 100 120
0
50
100
150
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 GMP
DAPI
H3K9me3
0 20 40 60 80 100 120
0
50
100
150
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 B cells
H3K9me3
DAPI
0 20 40 60 80 100 120
0
50
100
150
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 T cells
DAPI
H3K9me3
1 0 
0 
0 
0 
0 
0 
Nuclear  width (AU) 
Nuclear  width (AU) Nuclear  width (AU) 
Nuclear  width (AU) Nuclear  width (AU) 
Nuclear  width (AU) Nuclear  width (AU) 
DAPI 
H3K9me3 
ES
C
Figure 3. Subnuclear Distribution of Heterochromatin Is Altered upon Stem Cell Differentiation
(A) Immunohistochemistry for H3K9me3 revealed differential heterochromatin distribution in the nuclei of different cell types, gradually
shifting from adispersed distribution in ESCs to a tight, pericentric distribution inmature cells. LaminBwas used tomark thenuclear envelope.
(B) Average radial distribution of H3K9me3 (red line) across the width of the nucleus (indicated with a yellow box, top) superimposed on
DAPI stain (blue histogram) in the cell types displayed in (A). GMPs showed a less defined pattern, with significant foci in the center of the
nucleus, similar to ESCs. The distinct shape of the nuclear membrane of mature GM cells (bottom row in A) precluded comparative
quantification. n = 12 cells per cell type in three independent experiments.
(C) Quantification of the H3K9me3 distribution across the center (inner 60%) and periphery (outer 20% of each edge) of the nuclei of
different cell types demonstrated a progressive shift in H3K9me3 localization from the nuclear center to the periphery during stem cell
differentiation. As in (A) and (B), GMPs represent an exception to this pattern.
(D) Analysis of the fraction of heterochromatin, measured by SXT as heterochromatin volume, at increasing distance from the nuclear
envelope shows the accumulation of heterochromatin at the nuclear periphery in more differentiated cells. Mature GM and B cells (yellow
and green lines) have a thicker ring of heterochromatin close to the nuclear envelope, whereas ESCs (black line) have a very thin ring of
heterochromatin near the nuclear envelope.
Dataaremeans± SEM;*p<0.05, **p<0.01, and***p<0.001;ns, not significant. Statisticsbyone-wayANOVA. Scalebars, 2um.Seealso FigureS3.
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Figure 4. G9A Inhibition Uniquely Leads to Hematopoietic
Progenitor Accumulation In Vitro
Numbers of live cells and KLS cells after 5 days of in vitro liquid
culture of mouse HSCs (isolated as KLS Flk2-CD150+ BM cells) with
the G9A inhibitor UNC0638 at varying concentrations. The number
of KLS cells significantly increased at 0.1–1 uM of UNC0638 in
comparison to the DMSO-treated controls. The number of total live
cells started to significantly decline at 1 uM of UNC0638. Data
shown are calculated from n = 4 wells in two independent experi-
ments with HSCs grown in liquid culture. Similar results were ob-
tained when HSCs were grown on AFT024 stromal cells (data not
shown). On the basis of these data, we used UNC0638 at 0.3 uM for
subsequent experiments.
Statistical analyses for cell viability (open bars) and KLS cell
accumulation (black bars) relative to the vehicle control conditions
were determined using two-way ANOVA of three or more indepen-
dent experiments. *p% 0.05, **p% 0.01, and ***p% 0.001.gene expression of the KLS fraction after 5 days of in vitro
culturewith andwithoutUNC0638.We found a significant
number of upregulated genes in UNC0638-treated cells
previously associated with HSC function, such as Sox6,
Itga2b, Gata1, and Fgf3 (Figures 5D, S5A, and S5B) (Gekas
and Graf, 2013). Many of the genes upregulated with
UNC0638 treatment also have significantly higher expres-
sion in freshly isolated HSCs compared toMPPs, suggesting
that UNC0638 treatment delayed the silencing of genes
necessary for HSC differentiation (Figures 5D, S5A, and
S5B). We also identified significant downregulation of
genes involved in the regulation of HSC proliferation,
such as Egr1 (Min et al., 2008) and Ndn (Asai et al., 2012),
and HSC engraftment, such as Robo4 (Smith-Berdan et al.,
2011). Thus, UNC0638 led to maintenance of a large num-
ber of HSC-selective genes, whereas HSCs grown in the
absence of UNC0638 had a gene expression profile more
similar to MPPs, consistent with G9A inhibition leading
to delayed differentiation of HSCs into increasinglymature
progeny. Using chromatin immunoprecipitation (ChIP)
PCR, we found that several upregulated genes identified
by RNA sequencing (RNA-seq) have significantly lower
amount of H3K9me2 at their promoter (Figure 5E). TheStem Cell Rreduced levels of H3K9me2 at the promoter of these genes
suggest that they are directly regulated by G9A and that
G9A promotes their silencing upon HSC differentiation.
The same promoters also tended to have lower levels of
H3K9me3, but no changes in H3K4me3, indicating that
an increase in the activating H3K4me3 modification is
not necessary for increased gene expression. On the other
hand, downregulated genes had no significant changes in
H3K9me2 levels at their promoters, suggesting that their
downregulation is an indirect effect of G9A inhibition (Fig-
ure S5C). Collectively, these data suggest that the accumu-
lation of KLS cells in response to G9A inhibition reflects a
delay in HSC differentiation due to impaired silencing of
some, but not all, genes associated with differentiation.
Interestingly, gene set enrichment analysis (GSEA) and
gene ontology (GO) classification of RNA-seq data revealed
that a significant number of genes involved in cell migra-
tion were affected by UNC0638 (Figures 5D, 5F, S5A, and
S5B; Table S1), suggesting that G9A inhibition led to
impairedmigration capacity. One of the differentially regu-
lated genes, the G-protein-coupled receptor Cxcr4, plays
essential roles in HSC homing and engraftment by re-
sponding to the chemokine SDF1 (aka CXCL12) (Nagasawa
et al., 1998; Peled et al., 1999; Smith-Berdan et al., 2011;
Zou et al., 1998). To test the functional significance of
Cxcr4 dysregulation, we performed transwell migration as-
says toward SDF1. We found a significant decrease in the
migration efficiency of UNC0638-treated HSPCs, but not
myeloid progenitors, compared to the DMSO control (Fig-
ure 5G). Reduced migration efficiency, combined with the
increased fraction of cells in cycle (Figure 5B), which corre-
lates with poor HSC engraftment ability (Passegue´ et al.,
2005), likely explains the lack of increased reconstitution
by UNC0638-treated HSCs compared to untreated cells
(Figures 5C, S4A, and S4B). Nevertheless, our results suggest
that proper transition of euchromatic regions into silenced
heterochromatin, mediated in part by G9A, promotes the
developmental programs necessary for HSC maintenance
and efficient stem cell differentiation.DISCUSSION
Here, using several sensitive, complementary approaches,
we were able to assess the chromatin organization of rare,
primary hematopoietic cells. Our investigation revealed
how chromatin composition and organization dramati-
cally change from ESCs to HSCs, hematopoietic progenitor
cells, and terminally differentiated blood cells (Figures 1, 2,
3, S1, S2, and S3). We found that the large amount of
euchromatin present in pluripotent ESCs decreases gradu-
ally with lineage commitment (Figures 2A, 2B, and S2)
and that the layer of heterochromatin at the nucleareports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 The Authors 735
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envelope increases with cellular differentiation (Figures 3
and S3).We revealed a global, gradual change in chromatin
condensation between pluripotent and multipotent stem
cells and fully mature cells (Figures 1A, 1B, 2A–2C, and
S2A). It appears that both the amount of euchromatin
and the spatial distribution of heterochromatin define
the transition between stem and progenitor cells. The dif-
ferences in chromatin distribution likely affect the tran-
scriptional competence of a cell, being highly permissive
in ESCs, followed by an intermediate state in multipotent
HSCs and MPPs, and culminating in a highly restricted
chromatin conformation and the permanent silencing of
developmental programs in mature cells.
Interestingly, we found no major differences in global
chromatin composition or spatial organization between
HSCs and MPPs (Figures 1, 2, 3, S2, and S3), which differ
in self-renewal capability but share the capability to give
rise to all hematopoietic lineages (Boyer et al., 2011;
Forsberg et al., 2006). Myeloid-restricted GMPs also
have similar nuclease sensitivity and euchromatin
content. However, GMPs deviated significantly from
the ‘‘expected’’ increase in perinuclear localized hetero-
chromatin distribution that accompanied differentiation
in the other cases investigated (Figures 3A–3C and S3).
This ESC-like heterochromatin organization in GMPsFigure 5. G9A Inhibition Impairs HSC Differentiation In Vitro
(A) G9A inhibition via the inhibitor UNC0638 led to a significant increa
number (right bar graph) of KLS cells compared to the DMSO control. H
in vitro with or without UNC0638. n = 3 independent experiments.
(B) Cell-cycle analysis using EdU incorporation combined with Hoechs
cells were in S phase compared to the DMSO-treated controls (56% vers
cells. Myeloid progenitor cells harvested from the same wells displayed
(C) Hematopoietic reconstitution was not improved by UNC0638 treatm
of UNC0638 as in (A). After 24 hr of culture, KLS cells were sorted
transplanted into lethally irradiated recipients. Erythrocytes, platelet
no significant differences in reconstitution levels or lineage distributi
lineage over time for one out of three independent experiments, each
short-term (left graph; measured at 2–6 weeks post-transplantation
14 weeks post-transplantation for all cell types) reconstitution for eac
with 8–10 recipient mice per group. p values were determined using
(D) Gene expression analysis by RNA-seq (left) revealed a significant
compared to control cells grown without inhibitor (DESEQ padj < 0.01
by qRT-PCR (middle panel). The overlap (138 genes) of genes upregu
higher expression in freshly isolated HSCs compared to MPPs (635 g
promotes a more HSC-like expression. The intersect of differentiall
calculated by hypergeometric test (http://nemates.org/MA/progs/ov
(E) ChIP-qPCR demonstrated significantly reduced levels of H3K9me2
toward H3K9me3 reduction was also observed, but no differences were
(F) Gene set enrichment analysis (GSEA) of RNA-seq data from (D) r
differentially expressed gene category between control and UNC0638
(G) Transwell migration assay demonstrated an impaired capacity of
independent experiments.
Data are means ± SEM; *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not
S4 and S5.
Stem Cell Rmay be related to GMPs’ high reprogramming efficiency
(Eminli et al., 2009; Guo et al., 2014). As reprogramming
is more efficient in cells with highly dynamic epige-
nomes (Alabert and Groth, 2012), our findings are
important for understanding the mechanisms of differ-
ential reprogramming efficiency from different types of
adult cells.
Our inability to detect significant differences in the over-
all level of DNA methylation (Figure S1D) and individual
histone modifications (Figures 1C, 1D, and S1C–S1E) indi-
cates that the substantial chromatin condensation that oc-
curs upon stem cell differentiation cannot be attributed to
a single modification. Our data are supported by the lack of
overall changes in DNA methylation levels during HSC
differentiation (Bock et al., 2012; Ji et al., 2010) and by rela-
tively modest differences in global levels of histonemodifi-
cations between ESCs andMEFs by sensitive mass spectros-
copy (Sridharan et al., 2013). While the patterns of
individual modifications clearly change at gene regulatory
sites as stem cells differentiate, global levels of individual
marks seem to remain largely unchanged. Instead, rela-
tively small changes in multiple modifications may cumu-
latively lead to the global chromatin condensation that we
observed among pluripotent ESCs, multipotent HSPCs,
and mature hematopoietic cells.se in the frequency (flow cytometry plots; 66.8% versus 21.9%) and
SCs (isolated as KLS Flk2CD150+ BM cells) were cultured for 5 days
t staining revealed that a higher percentage of UNC0638-treated KLS
us 44%), demonstrating increased proliferation in UNC0638-treated
no differences in cell-cycle status. n = 3 independent experiments.
ent of HSCs. Purified HSCs were cultured in the presence or absence
from each condition, and equal numbers (500 per mouse) were
s, GM, B cells, and T cells were detected from both conditions, with
on. Line graphs display the peripheral blood reconstitution of each
performed with at least three recipient mice. Bar graphs display the
depending on cell type) or long-term (right graph; measured >
h lineage for all three experiments. n = 3 independent experiments
two-way ANOVA. No significant differences were observed.
number of upregulated HSC-related genes in UNC0638-treated cells
). The differential expression of a subset of these genes was verified
lated upon UNC0638 treatment of HSCs (650 genes) that also have
enes) is highly significant (right panel), indicating that UNC0638
y regulated genes was assessed by php coding, and the p value
erlap_stats.html). n = 3 independent experiments.
on promoters of putative G9A targets based on RNA-seq. A trend
found for the active mark H3K4me3. n = 3 independent experiments.
evealed that G-protein-coupled receptors is the most significantly
-treated HSCs.
UNC0638 KLS cells to migrate toward the chemokine SDF1. n = 3
significant. Statistical analysis by two-tailed t test. See also Figures
eports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 The Authors 737
We also showed that the chromatin remodeler G9A
plays an important role in HSC differentiation. We found
that lack of G9A function significantly impaired the differ-
entiation ability of HSCs in vitro and led to accumulation
of HSPCs (Figures 4 and 5A). Similar effects have been re-
ported by G9A inhibition in human hematopoietic pro-
genitor cells (Chen et al., 2012). G9A also regulates the
timing of pluripotency gene silencing upon ESC differen-
tiation (Yamamizu et al., 2012) and improves the reprog-
ramming efficiency of adult somatic cells into induced
pluripotent stem cells (iPSCs) (Shi et al., 2008). While
germline deletion of G9A results in embryonic lethality
(Tachibana et al., 2002), mice with hematopoietic-specific
deletion of G9A display few abnormalities (Lehnertz et al.,
2010). The clear effect on HSC differentiation in vitro by
inhibiting G9A with UNC0638 may therefore seem sur-
prising. A possible explanation is that HSCs are more
capable of compensating for lack of one epigenetic regu-
lator in vivo than they are in vitro, enabling them to
cope with loss of functionality that delays differentiation
in vitro. Collectively, our results and analogous studies
in ESCs and human HSCs suggest that G9A functions to
silence genes associated with the transition of stem cells
into lineage-committed cells. In our study, failure to
silence these genes led to a delay, but not complete block,
in HSC differentiation (Figures 4 and 5A). G9A inhibition,
alone, also failed to maintain genes necessary for robust
HSC engraftment upon transplantation (Figures 5C–5G,
S4, and S5; Table S1). Nevertheless, G9A has emerged as
an essential epigenetic regulator of stem cell function.
Our new insights on global chromatin composition and
distribution provide a solid platform for furthering a
deeper comprehension on the epigenetic regulation of
stem cell fate and function.EXPERIMENTAL PROCEDURES
Mice and Cells
All experiments were performed using 8- to 12-week-old C57BL/6
wild-typemice in accordancewithUCSC guidelines.Hematopoiet-
ic cells were isolated from BM isolated from murine femurs and
tibias as described (Forsberg et al., 2006; Beaudin et al., 2014;
Smith-Berdan et al., 2015). ESCs (E14) were cultured as described
(Gaspar-Maia et al., 2009).Nuclease Sensitivity
FACS-sorted cells were incubated for 6min at 37Cwith increasing
concentrations of DNaseI or micrococcal nuclease. Reactions were
terminated by adding equal volume of lysis buffer (10mMTris [pH
7.8], 0.1MEDTA, 10mMEGTA, and 0.5% SDS), 0.4mg/ml protein-
ase K, and 20 mg/mL of RNase and incubated at 42C for 2 hr. DNA
was isolated using phenol/chloroform and analyzed on 1%agarose
gels with SyberGold.738 Stem Cell Reports j Vol. 5 j 728–740 j November 10, 2015 j ª2015 TheElectron Microscopy
Fixed cells were ultrathin sectioned on a Reichert Ultracut S ultra-
microtome and counter-stained with 0.8% lead citrate. Grids were
examined on a JEOL JEM-1230 transmission electron microscope
and photographed with the Gatan Ultrascan 1000 digital camera
at the Gladstone Institute EM facility, San Francisco, CA, followed
by ImageJ analysis (Figure 2B).
Soft X-Ray Microscopy
FACS-sorted cells were mounted in thin-walled glass capillary
tubes and rapidly cryo-immobilized prior to mounting in a cryo-
genic specimen rotation stage of the XM-2 Soft X-ray microscope
(Le Gros et al., 2005). Three-dimensional tomograms were used
for calculations and movies (Movies S1, S2, and S3).
HSC Culturing and Transplantation
FACS-sorted HSCs (KLS Flk2-Slamf1+) were seeded at 100–500 cells
into 96-well plates and grown in liquid culture or on ATF024 stro-
mal cells. After culture with and without UNC0638 (Sigma), cells
were analyzed for cell surfacemarker expression by flow cytometry
and transplanted into congenic, irradiated C57BL/6 mice.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, five figures, two tables, and three movies and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2015.09.009.
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